Together, this indicates that amfra-/- zebrafish phenocopy disease mechanisms observed in HSP that are caused by AMFR dysfunction in humans and that treatment with statins improves the observed phenotypes in this preclinical model, possibly pointing toward a road to personalized medicine for this newly defined disorder. This evidence concerns the gene AMFR and hereditary spastic paraplegia.